Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Research Coverage on Small and Micro-Cap Companies

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Equity Bottom-Up

<ul><li>Lantheus is a leader in radiopharmaceutical offerings in oncology & precision diagnostics.</li><li>It offers a portfolio of diagnostic & therapeutic products directly & via partnerships & licensing.</li><li>The primary revenue driver is Pylarify, a PET tracer for PSMA-expressing prostate cancer.</li></ul>

Lantheus is a leader in radiopharmaceutical offerings in oncology & precision diagnostics.It offers a portfolio of diagnostic & therapeutic products directly & via partnerships & licensing.The primary revenue driver is Pylarify, a PET tracer for PSMA-expressing prostate cancer.

LNTH: Can AD Franchise Offset Pylarify Drag?

LNTH: Competition Escalates in PSMA Imaging

LNTH: Sale of SPECT Tilts Growth to Novel Radiopharmaceuticals

United States

Lantheus Holdings, Inc. develops, manufactures, sells, and distributes diagnostic medical imaging agents and products. The Company offers imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. Lantheus Holdings serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Lantheus Holdings (LNTH US)

LNTH: Can AD Franchise Offset Pylarify Drag?

Lantheus is a leader in radiopharmaceutical offerings in oncology & precision diagnostics. It offers a portfolio of diagnostic &...

Zacks Small Cap Research

LNTH: Competition Escalates in PSMA Imaging

Lantheus is a leader in radiopharmaceutical offerings in oncology & precision diagnostics. It offers a portfolio of diagnostic &...

Zacks Small Cap Research

LNTH: Sale of SPECT Tilts Growth to Novel Radiopharmaceuticals

Lantheus is a leader in radiopharmaceutical offerings in oncology & precision diagnostics. It offers a portfolio of diagnostic &...

Zacks Small Cap Research

LNTH: 2025 Guidance Provided

Lantheus is a leader in radiopharmaceutical offerings in oncology & precision diagnostics. It offers a portfolio of diagnostic &...

Zacks Small Cap Research

LNTH: Earnings Report Next Week

Lantheus is a leader in radiopharmaceutical offerings in oncology & precision diagnostics. It offers a portfolio of diagnostic &...

Zacks Small Cap Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)